Amphastar Pharmaceuticals Inc Archives

Home Tags Amphastar Pharmaceuticals Inc

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Files An 8-K Submission of Matters to...

ME Staff 8-k - June 13, 2019

Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) gets downgraded to Hold by Needham &...

ME Staff - March 13, 2019

Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) gets downgraded to Hold by Needham &...

ME Staff - March 13, 2019

Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) price target lowered to $22.00 by Needham...

ME Staff - August 10, 2018

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Files An 8-K Other Events

ME Staff 8-k - March 21, 2018

Insider Trading Activity Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) – Director Sold 5,000...

ME Staff - August 16, 2017

Insider Trading Activity Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) – Director Sold 10,000...

ME Staff - August 16, 2017

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Files An 8-K Other Events

ME Staff 8-k - July 24, 2017

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Files An 8-K Submission of Matters to...

ME Staff 8-k - June 9, 2017

/* */

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

September 18, 2023

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

September 11, 2023

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

August 21, 2023

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: Amphastar Pharmaceuticals Inc

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Files An 8-K Submission of Matters to...

Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) gets downgraded to Hold by Needham &...

Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) gets downgraded to Hold by Needham &...

Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) price target lowered to $22.00 by Needham...

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Files An 8-K Other Events

Insider Trading Activity Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) – Director Sold 5,000...

Insider Trading Activity Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) – Director Sold 10,000...

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Files An 8-K Other Events

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Files An 8-K Submission of Matters to...

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY